Arteris vs Synopsys
Synopsys is larger by market cap ($78.7B vs $1.4B). Synopsys reports higher tracked revenue ($7.1B vs $71M). Arteris's primary segment is Semiconductor IP Licensing; Synopsys's is EDA Software.
Shared segment: EDA & IP.
Side-by-side
| Arteris | Synopsys | |
|---|---|---|
| Market cap | $1.4B | $78.7B |
| Revenue | $71M (FY2025) | $7.1B (FY2025) |
| Primary segment | Semiconductor IP Licensing | EDA Software |
| Market position | niche | leader |
| Country | United States | United States |
| Tracked suppliers | 0 | 0 |
| Tracked customers | 8 | 11 |
| Chokepoint / criticality | 50/100 | 82/100 |
Market caps/revenue from the wafergraph dataset · data as of 2026-08-12. Criticality is a graph-derived chokepoint score (0–100). Coverage is partial; "Unpriced" means no reliable market cap.
How Arteris and Synopsys compare
- Size: Synopsys is the larger company by market cap.
- Revenue: Synopsys reports higher tracked revenue.
- Supply-chain criticality: Synopsys has the higher chokepoint score (82/100 vs 50/100).
- Footprint: Arteris (United States) vs Synopsys (United States).